Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)
Opal SM, Garber GE, LaRosa SP, et al. Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). Clinical Infectious Diseases. 2003;37:50–58.
This study finds that recombinant human drotrecogin alfa (activated) (DrotAA), administered in combination with standard antimicrobial therapies, can improve survival rates for severe sepsis.
|
This item has not yet been rated
|
 |
View article abstract
|
